The performance of companies tied to Sildenafil's legacy presents a complex investment scenario . While the initial boom generated substantial gains, generic copies have significantly impacted revenue. https://bookmarkbirth.com/story22291880/copyright-s-flagship-product-and-big-pharma-a-risky-opportunity